The STarT Back screening tool uses patient data to help doctors work out the chances of someone with back pain going on to develop a long term disability. By supporting doctors to find those most at risk, treatment can be targeted to where it is most needed, benefitting those with back pain and saving the NHS money.
Why was this work needed?
Lower back pain is estimated to affect 4 out of 5 people at some point in their lives, but it has been unclear how doctors should target treatment so that people get the most benefit.
STarT Back is a screening tool which helps doctors to group people with back pain according to their risk of developing a long term disability. Doctors ask nine questions about current symptoms and then use the answers to categorise the person as low, medium or high risk and then tailor their treatment accordingly.
What were the benefits?
The tool was originally developed as part of a randomised control trial showing that it could lead to improvements in symptoms, reduction in days off work and overall savings to the NHS. When doctors are treating conditions which are very common, such as back pain, using individual data in this way helps them to identify especially severe cases and target treatment accordingly.
What type of data was involved?
Patients are asked nine questions about their symptoms and the answers are used to help their doctor identify their risk category.
What was the legal basis for accessing the data?
The data is used in individual care as part of a consultation between a patient and their doctor.
Who funded and collaborated on this work?
Arthritis Research UK funded the trial which developed this tool, which was conducted at Keele University.
Where can I go for more information?
Follow Robert and his health data on their trip. How does Robert's health data move along with him? And how can his health data be reused?
01-09-2022 Last month, we finally published our report with our analysis of the 6.000 contributions we gathered through the Healthy Data consultation. Once ag... Read more
07-07-2022 Participation to our consultation has ended. Between December 2021 and May 2022, our platform received more than 24,500 visits and we collected alm... Read more